X T L Biopharmaceuticals Ltd (ADR)
General ticker "XTLB" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $9.7M
X T L Biopharmaceuticals Ltd (ADR) follows the US Stock Market performance with the rate: 22.2%.
Estimated limits based on current volatility of 7.0%: low 1.49$, high 1.72$
Factors to consider:
- Current price 31.2% above estimated high
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [0.57$, 1.43$]
- 2024-12-30 to 2025-12-30 estimated range: [0.61$, 1.49$]
Short-term XTLB quotes
Long-term XTLB plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $1.47MM | $0.00MM | $0.00MM |
| Operating Expenses | $2.50MM | $0.88MM | $0.77MM |
| Operating Income | $-1.03MM | $-0.88MM | $-0.77MM |
| Non-Operating Income | $1.47MM | $-0.47MM | $-1.02MM |
| Interest Expense | $0.02MM | $0.47MM | $0.00MM |
| R&D Expense | $0.03MM | $0.03MM | $0.03MM |
| Income(Loss) | $0.43MM | $-1.35MM | $-1.78MM |
| Taxes | $-1.47MM | $0.96MM | $0.00MM |
| Profit(Loss) | $1.90MM | $-2.31MM | $-1.78MM |
| Stockholders Equity | $5.33MM | $4.00MM | $2.22MM |
| Inventory | $0.00MM | $0.00MM | $0.03MM |
| Assets | $6.62MM | $4.19MM | $2.43MM |
| Operating Cash Flow | $-1.05MM | $-0.90MM | $-0.71MM |
| Investing Cash Flow | $0.01MM | $0.04MM | $0.04MM |
| Financing Cash Flow | $0.39MM | $0.00MM | $0.00MM |
| Earnings Per Share* | $0.36 | $-0.42 | $-0.00 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.